The University of Chicago Header Logo

Connection

James Zacny to Kaplan-Meier Estimate

Back to Details
This is a "connection" page, showing publications James Zacny has written about Kaplan-Meier Estimate.
James Zacny
Connection Strength
0.035
Kaplan-Meier Estimate
  1. Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors. Am J Clin Oncol. 2019 05; 42(5):413-420.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.